STORY: Swiss food giant vows to continue investment in China
SHOOTING TIME: Oct. 10-11, 2024
DATELINE: Oct. 17, 2024
LENGTH: 00:01:20
LOCATION: VEVEY, Switzerland
CATEGORY: ECONOMY

SHOTLIST:
1. various of Nestle's R&D center in Konolfingen
2. various of infant formula powders
3. SOUNDBITE 1 (English): ISABELLE BUREAU-FRANZ, Head of R&D Nutrition Business, Nestle
4. SOUNDBITE 2 (English): LAURENT ALSTEENS, Head of Global Category Business, Nestle
5. various of Nestle's headquarters in Vevey

STORYLINE:

With the release of new high-end infant formula products in China, Swiss food giant Nestle has vowed to continue cementing its market commitment and investment in China.

Illuma, a premium brand of maternal and infant nutrition under Nestle, has launched several Human Milk Oligosaccharides (HMO) products in China since the approval of two HMOs as food additives by China's National Health Commission a year ago.

SOUNDBITE 1 (English): ISABELLE BUREAU-FRANZ, Head of R&D Nutrition Business, Nestle
"In China, we have products containing two HMOs. We have a lot of cooperations today. We are looking also specifically at the taste of Chinese consumers. We are also adapting the Chinese nutritional solutions to the local regulatory requirement. You see, it's a lot about how do we use the global breakthrough discoveries and how we adapt to the local needs."

SOUNDBITE 2 (English): LAURENT ALSTEENS, Head of Global Category Business, Nestle
"We have also more and more invested in China over the past years. We have also factories in China, we have R&D centers in China. We are already very local in China, and that's for us a very important element. So China is clearly an important country for us to keep developing."

Xinhua News Agency correspondents reporting from Vevey, Switzerland.
(XHTV)